Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

CSTL Castle Biosciences PE ratio, current and historical analysis

The current PE ratio of CSTL cannot be calculated, as the latest EPS of -$0.15 is negative. The most recent PE ratio recorded for Castle Biosciences was 40.38 in December 2024.

CSTL PE ratio history

How has CSTL's PE ratio performed in the past
Today
N/A
Average
N/A
Median
N/A
Minimum
N/A
Maximum
N/A

Castle Biosciences PE ratio history chart

Castle Biosciences PE ratio by year

YearPE ratioPE changePriceEPS
202440.38N/A$26.65$0.66
2023N/AN/A$21.58-$2.14
2022N/AN/A$23.54-$2.58
2021N/AN/A$42.87-$1.24
2020N/AN/A$67.15-$0.54
201998.2N/A$34.37$0.35
2018N/AN/AN/A-$5.33
2017N/AN/AN/A-$8.08

CSTL Price vs fair value

How does CSTL's price compare to its estimated fair value based on its growth

CSTL average PE ratio chart

What is the average PE ratio of CSTL for the past years
3-year avg
N/A
5-year avg
N/A
10-year avg
N/A
15-year avg
N/A

PE vs average

CSTL PE vs peers

What is CSTL's PE ratio compared to its peers
Stock namePE ratioMarket cap
OPK Opko Health Inc N/A$1.09B
ORGO Organogenesis Holdings IncN/A$565.77M
CSTL Castle Biosciences Inc N/A$580.91M
Stock:
CSTL
OPK
ORGO
X axis
Y axis
Bubble size
Created with Highcharts 9.0.1EPS growth YoY (quarterly)Price to earnings (P/E)-900-850-800-750-700-650-600-550-500-450-400-350-300-250-200-150-100-500

Frequently asked questions

What is Castle Biosciences's PE ratio?

The current price to earnings ratio of CSTL cannot be determined, as its EPS of -$0.15 is negative.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.